Study how the microbiome may affect breast implant infections
Treatments studied
Part of Cancer, Skin clinical trials.
This Phase 2 study looks at whether changes in the body’s “microbiome” (the normal germs in and on the body) are linked to infections after breast surgery with implants. It may help doctors better predict and prevent implant infections in people undergoing mastectomy with immediate implant placement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have breast cancer confirmed by biopsy OR a genetic risk for breast cancer
- You are planning a mastectomy with immediate tissue expander or implant placement
- You completed chemotherapy or radiation at least 4 weeks ago
- You can read and sign the informed consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a probiotic supplement affects the bacteria and fungi in your gut, which may be linked to your breast cancer. You'll take a daily probiotic and have your diet and activity stay the same, to see if it helps your body respond to treatment.
This trial tests whether placing antibiotic beads near the surgical site during breast reconstruction can help prevent infections. It is for women having a mastectomy followed by immediate breast reconstruction with a tissue expander.
This study looks at how bacteria in your gut might relate to breast cancer. By comparing tissue samples from your tumor and nearby healthy tissue, researchers hope to find new ways to understand or treat breast cancer.
This trial looks at whether having breast implants changes what happens during routine breast cancer screening with mammograms. It may help improve how screening is done and understood for people with implants.
This study looks at how gut bacteria affect response to a type of targeted therapy (CDK4/6 inhibitors) combined with hormone therapy in breast cancer that is hormone receptor-positive and HER2-negative. It may help find out why some people respond better to treatment and could lead to better personalized care.
This study looks at how a dietary supplement (resistant starch) affects your gut bacteria while you take the breast cancer drug abemaciclib (Verzenio). It may help reduce side effects and improve your quality of life during treatment.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.